HER2 overexpression: In 15–20% of extrahepatic CCA and gallbladder carcinomas, there is observed overexpression or amplification of the EGFR family receptor tyrosine-protein kinase erbB-2 (HER2) [21]. This evidence concerns the gene ERBB2 and gallbladder carcinoma.